1	Nonradioactive	nonradioactive	_	_	_	_	_	_	_
2	quantification	quantification	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
5	receptor	receptor	_	_	_	_	_	_	_
6	expression	expression	_	_	_	_	_	_	_
7	during	during	_	_	_	_	_	_	_
8	differentiation	differentiation	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	human	human	_	_	_	_	_	_	_
11	monocytic	monocytic	_	_	_	_	_	_	_
12	cells	cell	_	_	_	_	_	_	_
13	(	(	_	_	_	_	_	_	_
14	U937	u937	_	_	_	_	_	_	_
15	)	)	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	describe	describe	_	_	_	_	_	_	_
3	a	a	_	_	_	_	_	_	_
4	method	method	_	_	_	_	_	_	_
5	for	for	_	_	_	_	_	_	_
6	relative	relative	_	_	_	_	_	_	_
7	quantification	quantification	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	specific	specific	_	_	_	_	_	_	_
10	mRNA	mrna	_	_	_	_	_	_	_
11	using	use	_	_	_	_	_	_	_
12	a	a	_	_	_	_	_	_	_
13	nonradioactive	nonradioactive	_	_	_	_	_	_	_
14	assay	assay	_	_	_	_	_	_	_
15	based	base	_	_	_	_	_	_	_
16	on	on	_	_	_	_	_	_	_
17	DNA	DNA	_	_	_	_	_	_	_
18	strand	strand	_	_	_	_	_	_	_
19	competition	competition	_	_	_	_	_	_	_
20	between	between	_	_	_	_	_	_	_
21	identical	identical	_	_	_	_	_	_	_
22	sequences	sequence	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	biotin-	biotin-	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	fluorescein-labeled	fluorescein-labeled	_	_	_	_	_	_	_
27	amplicon	amplicon	_	_	_	_	_	_	_
28	(	(	_	_	_	_	_	_	_
29	probe	probe	_	_	_	_	_	_	_
30	)	)	_	_	_	_	_	_	_
31	and	and	_	_	_	_	_	_	_
32	unlabeled	unlabeled	_	_	_	_	_	_	_
33	amplicon	amplicon	_	_	_	_	_	_	_
34	(	(	_	_	_	_	_	_	_
35	target	target	_	_	_	_	_	_	_
36	)	)	_	_	_	_	_	_	_
37	during	during	_	_	_	_	_	_	_
38	hybridization	hybridization	_	_	_	_	_	_	_
39	.	.	_	_	_	_	_	_	_

1	As	as	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	target	target	_	_	_	_	_	_	_
4	quantity	quantity	_	_	_	_	_	_	_
5	increased	increase	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	that	that	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	double-labeled	double-labeled	_	_	_	_	_	_	_
11	probe	probe	_	_	_	_	_	_	_
12	decreased	decrease	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	accordance	accordance	_	_	_	_	_	_	_
15	with	with	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	mass	mass	_	_	_	_	_	_	_
18	action	action	_	_	_	_	_	_	_
19	law	law	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	technique	technique	_	_	_	_	_	_	_
3	was	be	_	_	_	_	_	_	_
4	successfully	successfully	_	_	_	_	_	_	_
5	applied	apply	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	evaluate	evaluate	_	_	_	_	_	_	_
8	differences	difference	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
11	receptor	receptor	_	_	_	_	_	_	_
12	expression	expression	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	U937	u937	_	_	_	_	_	_	_
15	cells	cell	_	_	_	_	_	_	_
16	before	before	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	after	after	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	addition	addition	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	potent	potent	_	_	_	_	_	_	_
23	differentiation	differentiation	_	_	_	_	_	_	_
24	inducers	inducer	_	_	_	_	_	_	_
25	:	:	_	_	_	_	_	_	_
26	12-O-tetradecanoylphorbol	12-O-tetradecanoylphorbol	_	_	_	_	_	_	_
27	13-acetate	13-acetate	_	_	_	_	_	_	_
28	(	(	_	_	_	_	_	_	_
29	TPA	TPA	_	_	_	_	_	_	_
30	)	)	_	_	_	_	_	_	_
31	and	and	_	_	_	_	_	_	_
32	a	a	_	_	_	_	_	_	_
33	combination	combination	_	_	_	_	_	_	_
34	of	of	_	_	_	_	_	_	_
35	all-trans	all-trans	_	_	_	_	_	_	_
36	retinoic	retinoic	_	_	_	_	_	_	_
37	acid	acid	_	_	_	_	_	_	_
38	(	(	_	_	_	_	_	_	_
39	RA	RA	_	_	_	_	_	_	_
40	)	)	_	_	_	_	_	_	_
41	and	and	_	_	_	_	_	_	_
42	1,25-dihydroxyvitamin	1,25-dihydroxyvitamin	_	_	_	_	_	_	_
43	D2	d2	_	_	_	_	_	_	_
44	(	(	_	_	_	_	_	_	_
45	VD	VD	_	_	_	_	_	_	_
46	)	)	_	_	_	_	_	_	_
47	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	observed	observe	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	TPA	TPA	_	_	_	_	_	_	_
5	treatment	treatment	_	_	_	_	_	_	_
6	was	be	_	_	_	_	_	_	_
7	associated	associate	_	_	_	_	_	_	_
8	with	with	_	_	_	_	_	_	_
9	an	an	_	_	_	_	_	_	_
10	increase	increase	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	specific	specific	_	_	_	_	_	_	_
13	binding	binding	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	[	[	_	_	_	_	_	_	_
16	3H]dexamethasone	3H]dexamethasone	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	up-regulation	up-regulation	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	GR	GR	_	_	_	_	_	_	_
21	mRNA	mRNA	_	_	_	_	_	_	_
22	while	while	_	_	_	_	_	_	_
23	no	no	_	_	_	_	_	_	_
24	enhanced	enhance	_	_	_	_	_	_	_
25	GR	gr	_	_	_	_	_	_	_
26	expression	expression	_	_	_	_	_	_	_
27	was	be	_	_	_	_	_	_	_
28	perceived	perceive	_	_	_	_	_	_	_
29	with	with	_	_	_	_	_	_	_
30	RA/VD	RA/VD	_	_	_	_	_	_	_
31	treatment	treatment	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

